Apria Reports Definitive Agreement to be Acquired by Owens & Minor
Jan 10, 2022 By MarketDepth
Apria, Inc. (NASDAQ: APR) and Owens & Minor, Inc. (NYSE: OMI) has reported entry into a definitive agreement where Owens & Minor will acquire Apria for USD 37.50 in cash per share of common stock, representing a value of USD 1.45 Billion. “I’m very excited about the acquisition of Apria, which will strengthen our total company value proposition. The combination of two complementary businesses in Byram Healthcare and Apria will enable us to better serve the entire patient journey – through the hospital and into the home – ultimately furthering our mission of Empowering Our Customers to Advance Healthcare,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor. “In addition, this transaction diversifies our total company revenue stream by expanding our presence in the higher-growth home healthcare market.”
“We are impressed by what Apria has built for its customers, and I look forward to welcoming Dan Starck and the Apria team to Owens & Minor upon close.”
Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor
“I am energized and enthusiastic to join Owens & Minor,” said Dan Starck, Chief Executive Officer of Apria. “Both companies share cultures fueled by a commitment to customers, patients, teammates and the communities we serve. We look forward to joining together and delivering the highest quality healthcare solutions to our customers.”
Transaction Approved by Board
The board of director from each company have approved the transaction. The transaction is subject to customary closing conditions such as the Hart Scott Rodino Act and other regulatory approvals which is expected to close within the first half of 2022.
